Silence Therapeutics PLC (SLN)

Back to homepage

Company Description

Silence Therapeutics PLC was incorporated on November 18, 1994. The Company with its subsidiaries is engaged in the research and development of novel pharmaceutical products. The Company discovers, develops and delivers novel RNAi therapeutics for the treatment of serious diseases. The Company's RNAi therapeutic platform is comprised of proprietary delivery technologies, potent siRNA sequences and siRNA structural features. Its products include Atu027, currently in a Phase 2a clinical trial; AtuPLEX, for endothelial cells of the vascular system; and among others. The Company has operations in Europe, North America, and Asia-Pacific...


About Company REFS

Company REFS (Really Essential Financial Statistics) is the UK's leading stock selection tool, with a wealth of investment facts and figures you won’t find together in any other single source. No other stock selection tool tells you so much about a UK quoted company’s prospects – on one, easy-to-read page.

Here’s what a Company REFS subscription brings you, all in one complete convenient source:

  • The latest company information and fundamental data from the London Stock Exchange - updated daily
  • Coverage of ALL 1700+ UK listed and domiciled stocks (excluding investment trusts) - including AIM
  • Uniform presentation of data - for easy like-for-like comparison of companies
  • Directors' share-dealing transactions over the last six months
  • League tables that instantly compare a company’s performance within its index against the market overall
  • Consensus broker forecasts and changes - based on data from over 300 contributing brokers
  • Sector statistics comparing each company with all the others in its peer group

Only REFS market rankings and individual profiles give you the complete investment picture.

Company REFS is available in two formats:

  • Online: With data and prices updated daily, you can easily sort and search for stocks that meet your investment criteria, as well as create personalised portfolios and watchlists.
  • Hard copy: Available as a monthly or quarterly edition, the hard copy of Company REFS comes in a handy ring binder format, with one page of per company – so you can easily compare stocks side by side.